DrugPatentWatch Database Preview
Details for Patent: 8,252,776
Which drugs does patent 8,252,776 protect, and when does it expire?
Patent 8,252,776 protects XIMINO and SOLODYN and is included in two NDAs.
This patent has thirteen patent family members in ten countries.
Summary for Patent: 8,252,776
| Title: | Minocycline oral dosage forms for the treatment of acne |
| Abstract: | Minocycline oral dosage forms containing a controlled release carrier are useful for the treatment of acne. |
| Inventor(s): | Wortzman; Mitchell (Scottsdale, AZ), Plott; R. Todd (Briscoe, TX), Bhatia; Kuljit (Nesconset, NY), Patel; Bhiku (Chandler, AZ) |
| Assignee: | Medicis Pharmaceutical Corporation (Scottsdale, AZ) |
| Application Number: | 11/695,513 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,252,776 |
|
Patent Claim Types: see list of patent claims | Use; Dosage form; Composition; |
Drugs Protected by US Patent 8,252,776
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharm Inds Inc | XIMINO | minocycline hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 201922-001 | Jul 11, 2012 | RX | No | No | Start Trial | Start Trial | TREATMENT OF ACNE | Start Trial | ||||
| Sun Pharm Inds Inc | XIMINO | minocycline hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 201922-003 | Jul 11, 2012 | RX | No | No | Start Trial | Start Trial | TREATMENT OF ACNE | Start Trial | ||||
| Sun Pharm Inds Inc | XIMINO | minocycline hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 201922-005 | Jul 11, 2012 | RX | No | No | Start Trial | Start Trial | TREATMENT OF ACNE | Start Trial | ||||
| Medicis | SOLODYN | minocycline hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 050808-001 | May 8, 2006 | DISCN | Yes | No | Start Trial | Start Trial | TREATMENT OF ACNE | Start Trial | ||||
| Medicis | SOLODYN | minocycline hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 050808-008 | Aug 27, 2010 | AB | RX | Yes | No | Start Trial | Start Trial | TREATMENT OF ACNE | Start Trial | |||
| Medicis | SOLODYN | minocycline hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 050808-004 | Jul 23, 2009 | AB | RX | Yes | No | Start Trial | Start Trial | TREATMENT OF ACNE | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,252,776
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2006262428 | Start Trial | |||
| Canada | 2613273 | Start Trial | |||
| China | 101208097 | Start Trial | |||
| European Patent Office | 1898925 | Start Trial | |||
| Israel | 188331 | Start Trial | |||
| Japan | 2008543936 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
